Rusch V - Search Results

1

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, Motoi N, Szoke J, Reinersman JM, Major J, Sander C, Seshan VE, Zakowski MF, Rusch V, Pao W, Gerald W, Ladanyi M. Chitale D, et al. Among authors: rusch v. Oncogene. 2009 Aug 6;28(31):2773-83. doi: 10.1038/onc.2009.135. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525976 Free PMC article.

2

Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Martini N, et al. Among authors: rusch vw. J Thorac Cardiovasc Surg. 1995 Jan;109(1):120-9. doi: 10.1016/S0022-5223(95)70427-2. J Thorac Cardiovasc Surg. 1995. PMID: 7815787 Free article.

3

Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors.

Ahn MJ, Langenfeld J, Moasser MM, Rusch V, Dmitrovsky E. Ahn MJ, et al. Among authors: rusch v. Oncogene. 1995 Dec 7;11(11):2357-64. Oncogene. 1995. PMID: 8570187

4

Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial.

McCormack PM, Bains MS, Begg CB, Burt ME, Downey RJ, Panicek DM, Rusch VW, Zakowski M, Ginsberg RJ. McCormack PM, et al. Among authors: rusch vw. Ann Thorac Surg. 1996 Jul;62(1):213-6; discussion 216-7. doi: 10.1016/0003-4975(96)00253-6. Ann Thorac Surg. 1996. PMID: 8678645 Clinical Trial.

5

Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation.

Langenfeld J, Lonardo F, Kiyokawa H, Passalaris T, Ahn MJ, Rusch V, Dmitrovsky E. Langenfeld J, et al. Among authors: rusch v. Oncogene. 1996 Nov 7;13(9):1983-90. Oncogene. 1996. PMID: 8934545

6

Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma.

Ebright MI, Zakowski MF, Martin J, Venkatraman ES, Miller VA, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Ebright MI, et al. Ann Thorac Surg. 2002 Nov;74(5):1640-6; discussion 1646-7. doi: 10.1016/s0003-4975(02)03897-3. Ann Thorac Surg. 2002. PMID: 12440623

7

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.

Illei PB, Ladanyi M, Rusch VW, Zakowski MF. Illei PB, et al. Cancer. 2003 Feb 25;99(1):51-6. doi: 10.1002/cncr.10923. Cancer. 2003. PMID: 12589646 Free article. Clinical Trial.

8

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Illei PB, et al. Clin Cancer Res. 2003 Jun;9(6):2108-13. Clin Cancer Res. 2003. PMID: 12796375

9

SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.

Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B. Sarkaria IS, et al. Ann Thorac Surg. 2004 Nov;78(5):1734-41. doi: 10.1016/j.athoracsur.2004.05.056. Ann Thorac Surg. 2004. PMID: 15511464 Review.

10

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.

Pham D, Kris MG, Riely GJ, Sarkaria IS, McDonough T, Chuai S, Venkatraman ES, Miller VA, Ladanyi M, Pao W, Wilson RK, Singh B, Rusch VW. Pham D, et al. J Clin Oncol. 2006 Apr 10;24(11):1700-4. doi: 10.1200/JCO.2005.04.3224. Epub 2006 Feb 27. J Clin Oncol. 2006. PMID: 16505411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters